[1]JournalofMedicinalChemistry,1990,vol.33,p.2535-2544
[1]Robb,KevinA.;Athavale,SoumitraV.;Denmark,ScottE.[Synlett,2019,vol.30,#14,p.1656-1661]
405-06-1
351-52-0
339586-05-9
125369-56-4
1391033-24-1
1716-43-4
258346-69-9 | 1-(4-(Trifluoromethyl)phenyl)butane-1,3-dione | AA00C19C | MFCD07772941
214750-74-0 | Fmoc-d-orn(aloc)-oh | AA00C1HX | MFCD00042444
2344-09-4 | 2-(Trifluoromethyl)dioxolane | AA00C1QN | MFCD04038366
31130-15-1 | 5-(4-methylphenyl)-1,3,4-oxadiazole-2-thiol | AA00C1V0 | MFCD02816988
27465-52-7 | 1-(4-Isopropylphenyl)propan-1-one | AA00C1ZG | MFCD01095865
25756-29-0 | (Cyclohexylmethyl)(methyl)amine | AA00C245 | MFCD01734787
2138-34-3 | 3-(Dimethylamino)-4'-bromopropiophenone | AA00C2B3 | MFCD00456294
241142-94-9 | N-Biotinyl Dopamine | AA00C2IO | MFCD28125410
28116-23-6 | 2-(2-(4-Hydroxyphenyl)acetamido)acetic acid | AA00C2OZ | MFCD11188516
21752-32-9 | L-Methionine [S]-Sulfoximine | AA00C2TZ | MFCD00002621